|
|
|
Insider
Information: |
Wierenga Wendall D |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
161,985 |
|
Indirect Shares
|
15,373 |
|
|
Direct
Value |
$7,036,021 |
|
|
Indirect Value
|
$1,634 |
|
|
Total
Shares |
177,358 |
|
|
Total
Value |
$7,037,655 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
122.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
EVP, Research & Develo... |
2003-10-10 |
5,023 |
2003-09-01 |
0 |
Premium* |
|
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2013-10-01 |
0 |
2003-11-03 |
0 |
Premium* |
|
Xenoport Inc |
XNPT |
Director |
2016-07-05 |
0 |
2006-12-15 |
0 |
Premium* |
|
Santarus Inc |
SNTS |
EVP, R&D |
2014-01-02 |
0 |
2014-01-02 |
0 |
Premium* |
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director |
2014-03-13 |
12,389 |
|
0 |
Premium* |
|
Seelos Therapeutics Inc |
SEEL |
Director |
2014-10-22 |
20,000 |
2017-01-05 |
15,373 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
Director |
2017-12-11 |
0 |
2015-06-23 |
0 |
Premium* |
|
Cytokinetics Inc |
CYTK |
Director |
2024-01-02 |
18,727 |
2020-04-28 |
0 |
Premium* |
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
Director |
2023-06-16 |
105,846 |
2020-04-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XNPT |
Xenoport Inc |
Director |
|
2005-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,998 |
|
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2014-03-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,389 |
|
- |
|
XNPT |
Xenoport Inc |
Director |
|
2006-11-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
15,998 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
Director |
|
2009-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
580 |
580 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
Director |
|
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,580 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
Director |
|
2010-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,580 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
Director |
|
2011-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,580 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
Director |
|
2012-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
8,580 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
Director |
|
2012-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
9,830 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
Director |
|
2013-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
11,180 |
0 |
- |
|
XNPT |
Xenoport Inc |
Director |
|
2013-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
8,998 |
0 |
- |
|
XNPT |
Xenoport Inc |
Director |
|
2014-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
13,998 |
0 |
- |
|
XNPT |
Xenoport Inc |
Director |
|
2015-05-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
33,998 |
0 |
- |
|
XNPT |
Xenoport Inc |
Director |
|
2016-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
38,998 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2017-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
11,250 |
15,373 |
0 |
- |
|
OCRX |
Ocera Therapeutics Inc |
Director |
|
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
17,500 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2021-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,920 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2022-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
12,033 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
17,831 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
Director |
|
2023-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
105,846 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2021-07-07 |
4 |
A |
$19.77 |
$1,246 |
D/D |
63 |
6,459 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2016-04-05 |
4 |
A |
$0.58 |
$2,813 |
I/I |
4,850 |
24,850 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2016-06-30 |
4 |
A |
$0.40 |
$3,000 |
I/I |
7,510 |
32,360 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2016-09-30 |
4 |
A |
$0.34 |
$3,000 |
I/I |
8,868 |
41,228 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2022-04-01 |
4 |
A |
$38.38 |
$5,603 |
D/D |
146 |
7,033 |
0 |
- |
|
85 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|